Cargando…

Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy

CONTEXT: We describe the clinical investigation of the first generation aldosterone synthase inhibitor, LCI699, in patients with essential, uncontrolled, resistant, or secondary hypertension. LCI699 competitively reduced blood pressure at lower doses yet counterintuitive effects were observed at hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schumacher, Christoph D., Steele, Ronald E., Brunner, Hans R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2013
Materias:	ORIGINAL PAPERS: Therapeutic aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771574/ https://www.ncbi.nlm.nih.gov/pubmed/24107737 http://dx.doi.org/10.1097/HJH.0b013e328363570c

Ejemplares similares

Long-term effect of specific treatment of primary aldosteronism on carotid intima–media thickness
por: Holaj, Robert, et al.
Publicado: (2015)

Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial
por: Mathiassen, Ole N., et al.
Publicado: (2016)

Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry
por: Song, Jie, et al.
Publicado: (2016)

Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension
por: Schmieder, Roland E., et al.
Publicado: (2021)

Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012
por: Sengul, Sule, et al.
Publicado: (2016)

Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China
por: Wang, Zengwu, et al.
Publicado: (2017)

Effects of a nationwide strategy to reduce salt intake in Samoa
por: Trieu, Kathy, et al.
Publicado: (2018)

Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis
por: Rakugi, Hiromi, et al.
Publicado: (2015)

Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial
por: Mancia, Giuseppe, et al.
Publicado: (2014)

A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension
por: Cushman, William C., et al.
Publicado: (2018)

Patients’ and healthcare providers’ perceptions and practices regarding hypertension, pharmacy-based care, and mHealth in Lagos, Nigeria: a mixed methods study
por: Cremers, Anne L., et al.
Publicado: (2019)

Low medication adherence is associated with decline in health-related quality of life: results of a longitudinal analysis among older women and men with hypertension
por: Peacock, Erin, et al.
Publicado: (2021)

Effects of risk assessment and management programme for hypertension on clinical outcomes and cardiovascular disease risks after 12 months: a population-based matched cohort study
por: Yu, Esther Y.T., et al.
Publicado: (2017)

The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants
por: Baumann, Pierre, et al.
Publicado: (2005)

Identification of thymidylate synthase as a potential therapeutic target for lung cancer
por: Takezawa, K, et al.
Publicado: (2010)

The therapeutic transnosological use of psychotropic drugs
por: Ackenheil, Manfred, et al.
Publicado: (1999)

Promising avenues of therapeutics for bipolar illness
por: Post, Robert M.
Publicado: (2008)

Therapeutic options and challenges for substances of abuse
por: Gardner, Tracie J., et al.
Publicado: (2007)

Therapeutic approaches to age-associated neurocognitive disorders
por: O'Hara, Ruth, et al.
Publicado: (2001)

Mechanistic modelling of dynamic MRI data predicts that tumour heterogeneity decreases therapeutic response
por: Venkatasubramanian, R, et al.
Publicado: (2010)

Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
por: Coyle, Joseph T., et al.
Publicado: (2010)

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
por: Bilim, V, et al.
Publicado: (2009)

More rigorous protocol adherence to intensive structured management improves blood pressure control in primary care: results from the Valsartan Intensified Primary carE Reduction of Blood Pressure study
por: Stewart, Simon, et al.
Publicado: (2014)

Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model
por: Cohen-Mazor, Meital, et al.
Publicado: (2014)

Time of administration important? Morning versus evening dosing of valsartan
por: Zappe, Dion H., et al.
Publicado: (2015)

Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes
por: White, William B., et al.
Publicado: (2016)

Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report
por: Dell’Oro, Raffaella, et al.
Publicado: (2017)

A novel angiotensin II peptide vaccine without an adjuvant in mice
por: Nakamaru, Ryo, et al.
Publicado: (2021)

Neural plasticity: consequences of stress and actions of antidepressant treatment
por: Duman, Ronald S.
Publicado: (2004)

Aldosterone synthase inhibitors in hypertension: current status and future possibilities
por: Hargovan, Milan, et al.
Publicado: (2014)

Pharmacologic treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2010)

Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas
por: Rahman, M T, et al.
Publicado: (2012)

Inhibition of the reward system by antipsychotic treatment
por: Juckel, Georg
Publicado: (2016)

Effects of different antidepressant treatments on the core of depression
por: Baghai, Thomas C., et al.
Publicado: (2008)

Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer
por: Lilge, Lothar, et al.
Publicado: (2020)

Non-steroidal anti-inflammatory drug (NSAID) related inhibition of aldosterone glucuronidation and arterial dysfunction in patients with rheumatoid arthritis: a cross-sectional clinical study
por: Crilly, Michael A, et al.
Publicado: (2011)

Oral Therapeutics Post Menopausal Osteoporosis
por: Schroeder, Ryan J, et al.
Publicado: (2023)

Insights on β‐blockers for the treatment of hypertension: A survey of health care practitioners
por: Egan, Brent, et al.
Publicado: (2018)

Full Activation of CD4(+) T Cells Early During Sepsis Requires Specific Antigen
por: Schmoeckel, Katrin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3lgfe496bgaviaki7mc3d4tqhs